Daily Oncology News

The ESMO OncologyPRO news, provided in partnership with medwireNews, ensures that you're always kept up to date with the latest developments in the field of medical oncology. You can browse articles by date or by topic.

Did you know how medwireNews writes our articles?

Filter

Date Title Topic
23 Jun 2017 Taxane Switch Boosts PSA Reduction Success For Metastatic CRPC Anti-Cancer Agents & Biologic Therapy - Prostate Cancer
22 Jun 2017 CONVERT Fails To Show Once Daily Chemoradiotherapy Regimen Superiority For Limited-Stage SCLC Surgery and/or Radiotherapy of Cancer
21 Jun 2017 OS Equal For Cetuximab And Bevacizumab In Advanced KRAS Wild-Type CRC Anti-Cancer Agents & Biologic Therapy - Colon Cancer - Rectal Cancer
20 Jun 2017 12-Month OS Best Current Predictor Of Metastatic NSCLC Trial OS Endpoint Anti-Cancer Agents & Biologic Therapy - Cancer Immunology and Immunotherapy - Non-Small-Cell Lung Cancer, Metastatic
19 Jun 2017 Lenvatinib Effective For Radioiodine-Refractory Differentiated Thyroid Cancer Patients Of All Ages Anti-Cancer Agents & Biologic Therapy - Thyroid Cancer
16 Jun 2017 Small Bowel Adenocarcinoma Shows ‘Unique’, Targetable Genomic Profile Gastrointestinal Cancers - Pathology/Molecular Biology
15 Jun 2017 Brentuximab Vedotin ‘Potentially Practice Changing’ For Cutaneous T-Cell Lymphoma Anti-Cancer Agents & Biologic Therapy - Haematologic Malignancies - Lymphomas
14 Jun 2017 Second-Line Ceritinib Best For ALK-rearranged NSCLC After Crizotinib Anti-Cancer Agents & Biologic Therapy - Non-Small-Cell Lung Cancer, Metastatic - Personalised Medicine
13 Jun 2017 ASCO 2017: KEYNOTE-045, -052 Support Pembrolizumab For Advanced Urothelial Cancer Populations Cancer Immunology and Immunotherapy - Urothelial Cancers
12 Jun 2017 ASCO 2017: Updated KEYNOTE-024 OS, PFS2 Findings Positive For First-Line Pembrolizumab In NSCLC Cancer Immunology and Immunotherapy - Non-Small-Cell Lung Cancer, Metastatic
09 Jun 2017 ASCO 2017: ARCHER Supports First-Line Dacomitinib For Advanced EGFR-Mutated NSCLC Anti-Cancer Agents & Biologic Therapy - Non-Small-Cell Lung Cancer, Metastatic
09 Jun 2017 ASCO 2017: Lenvatinib Matches Sorafenib Efficacy In Unresectable HCC Anti-Cancer Agents & Biologic Therapy - Hepatobiliary Cancers
08 Jun 2017 ASCO 2017: Nivolumab Plus Ipilimumab Effective Against Melanoma Brain Metastases Cancer Immunology and Immunotherapy - Melanoma and other Skin Tumours
07 Jun 2017 ASCO 2017: Electronic Self-Reported Symptom Monitoring Prolongs Metastatic Cancer OS Supportive Care
06 Jun 2017 ASCO 2017: ADJUVANT Gefitinib May Prevent Recurrent EGFR-Mutated NSCLC Anti-Cancer Agents & Biologic Therapy - Non-Small-Cell Lung Cancer, Early Stage - Personalised Medicine